Loading organizations...
§ Private Profile · Germantown, MD, USA
Biotech company developing treatments for neurodegenerative diseases.
Neuraly has raised $36.0M across 1 funding round.
Neuraly has raised $36.0M in total across 1 funding round.
Neuraly has raised $36.0M in total across 1 funding round.
Neuraly's investors include D&D Pharmatech, Dongkoo Bio&Pharma, Geon Investment, Junghee Lim, LB Investment, Keele Park, Phillip Jung, Octave Life Sciences, John Ku.
Neuraly has raised $36.0M across 1 funding round. Most recently, it raised $36.0M Series A in July 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 18, 2018 | $36M Series A | D&D Pharmatech | Dongkoo Bio&pharma, Geon Investment, Junghee LIM, LB Investment, Keele Park, Phillip Jung, Octave Life Sciences, John KU | Announced |